education
Download App
Indonesia
search
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Download App
Country
Indonesia
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Iklan
Iklan
MIMS home
Drugs
Info
Surevit D3
Surevit D3
colecalciferol
Manufacturer:
SDM Lab
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Full Prescribing Info
Contents
Description
Indications/Uses
Dosage/Direction for Use
Storage
MIMS Class
ATC Classification
Presentation/Packing
Concise Prescribing Info
Bahasa Concise Prescribing Info
Full Prescribing Info
Contents
Description
Indications/Uses
Dosage/Direction for Use
Storage
MIMS Class
ATC Classification
Presentation/Packing
Concise Prescribing Info
Contents
Vit D
3
(cholecalciferol)
Indications/Uses
To fulfill vit D requirement in certain conditions eg, elderly, pregnant & nursing women. Patients at high risk or suffering from infectious or autoimmune diseases.
Click to view Surevit D3 detailed prescribing information
Dosage/Direction for Use
1 tab 1-3 times daily.
Click to view Surevit D3 detailed prescribing information
Administration
Should be taken with food.
Storage
View
Surevit D3 storage
conditions for details to ensure optimal shelf-life.
Description
View
Surevit D3 description
for details of the chemical structure and excipients (inactive components).
MIMS Class
Vitamins A, D & E
ATC Classification
A11CC05 - colecalciferol ; Belongs to the class of vitamin D and analogues. Used as dietary supplements.
Presentation/Packing
Form
Surevit D3 tab 1,000 IU
Packing/Price
5 × 6's
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk